Eli Lilly reveals plans for new high-tech parenteral manufacturing site
European Pharmaceutical Review
NOVEMBER 20, 2023
Supporting European parenteral manufacture and supply Alongside expanding the company’s global parenteral product and device manufacturing network, the new facility will support the higher demand for Eli Lilly’s medicines, including its diabetes and obesity portfolio. This includes automation and high-speed manufacturing lines.
Let's personalize your content